ÂÜŔňÂŇÂ×

Kunihiko Suzuki is one of the business leaders in Regenerative Medicine/Cell & Gene Therapy space in Japan.

While Kuni started his business career at US oil company in Tokyo/Kyoto and spent circa. 20 years at one of Japanese financial institutions in the areas of investment banking in Tokyo, commercial banking in London and trust banking in Luxembourg, Kuni moved into the space of RM/CGT sector in 2006 as one of management team (Member of the Board, CBO, CEO and other positions) of MEDINET Co., Ltd., one of the earliest companies focused on immune-cell therapies and contract development and manufacturing (CDMO) services.

Additionally, Kuni was one of the establishing committee members of Japan’s industry associate, FIRM (Forum for Innovative Regenerative Medicine) which acts as the nation’s industrial advocacy group, similar to the US-based ARM, Alliance for Regenerative Medicine. He was a Member of the Board and Vice Chair of FIRM since 2014 and, in April 2021, was invited be a leader of FIRM’s Specific Cell-based Products Working Group.

In April 2020, Kuni became a Member of the Bio-Industry Subcommittee of the Commerce, Distribution and Information Committee for the Industrial Structure Council of Japan’s METI (Ministry of Economy, Trade and Industry) to issue the report, “Fifth Industrial Revolution” cultivated with Biotechnology. Recently Kuni was also a Co-Chair of Organising Committee for the ISCT Melbourne 2019 Annual Meeting as well as the ISCT Regional Treasurer, Asia for the 2020-2023 term.

n December 2020, Kuni became an Advisor to Cyfuse Biomedical K.K., a company producing regenerative medical products with its own unique 3D bio-printing technology (the KENZAN method), and was appointed to Cyfuse’s Board of Directors in March 2021. In May 2021, Kuni became an associate member of the advisory firm Cell One Partners, based in New York, charged with advising clients related to their RM/CGT activities in Japan/Asia markets.

Kuni holds an M.A. in Economics from Waseda University and an MBA from Keio University.